Tanaka K
Third Department of Internal Medicine, Fukushima Medical College.
Nihon Naibunpi Gakkai Zasshi. 1992 Nov 20;68(11):1177-87. doi: 10.1507/endocrine1927.68.11_1177.
The aim of the present study is to explore whether the renal and cardiovascular response to clonidine in type II diabetic patients is different from that in control subjects, and to clarify the role of central alpha 2-receptor in the regulation of cardiovascular response and sodium handling in type II diabetes mellitus (DM). Thirty-five diabetic inpatients aged 30-71 years (54.1 +/- 9.7) and ten control subjects (N) were enrolled in this study after their fasting plasma glucose had been improved. To evaluate the peripheral sympathetic nerve activity, 24-hour urinary catecholamine was measured, and pulse rate (PR) responses to a 30-second standing test was determined. On another day, blood pressure (BP), PR, plasma norepinephrine (PNE), cyclic AMP (p-cAMP), renin activity (PRA), aldosterone (PAC) and growth hormone (p-GH) were measured at 0, 30, 60, 90, 120, 150, 180 minutes following the oral administration of clonidine (150 micrograms). Type II DM were classified as DM with hyper-response (DM-HR, n = 12) when their PR decreased after clonidine more than that of N, and if not, they were classified as DM with normal response (DM-NR, n = 23). Urinary catecholamine excretions in type II DM were within the normal range. BP, PNE and p-cAMP were markedly decreased with clonidine in similar fashion in DM-NR, DM-HR and N. The percent changes of PNE were correlated positively with the changes of p-cAMP in both N and DM-NR (r = 0.660 and 0.449, respectively), but not in DM-HR. No significant difference in the changes of p-GH (delta p-GH) and integral of GH (the area under the curve) following clonidine administration was observed in the three groups. The decrease in PR was correlated with neither delta p-GH (N: r = 0.082, DM-NR: r = -0.400, DM-HR: r = 0.242) or integral of GH (N: r = 0.191, DM-NR: r = 0.382, DM-HR: r = 0.162). The fractional excretion of sodium (FENa) decreased in N (p < 0.01), increased in DM-NR (p < 0.05) and did not change in DM-HR. The changes of FENa were not correlated with those of PRA and PAC.(ABSTRACT TRUNCATED AT 400 WORDS)
本研究的目的是探讨II型糖尿病患者对可乐定的肾脏和心血管反应是否与对照受试者不同,并阐明中枢α2受体在II型糖尿病(DM)心血管反应调节和钠处理中的作用。35例年龄在30 - 71岁(54.1±9.7)的糖尿病住院患者和10名对照受试者在空腹血糖得到改善后纳入本研究。为评估外周交感神经活动,测量24小时尿儿茶酚胺,并测定对30秒站立试验的脉搏率(PR)反应。在另一天,口服可乐定(150微克)后0、30、60、90、120、150、180分钟测量血压(BP)、PR、血浆去甲肾上腺素(PNE)、环磷酸腺苷(p - cAMP)、肾素活性(PRA)、醛固酮(PAC)和生长激素(p - GH)。当II型糖尿病患者服用可乐定后PR下降幅度超过对照受试者时,将其分类为高反应性糖尿病(DM - HR,n = 12),否则分类为正常反应性糖尿病(DM - NR,n = 23)。II型糖尿病患者的尿儿茶酚胺排泄在正常范围内。在DM - NR、DM - HR和对照受试者中,可乐定使BP、PNE和p - cAMP以相似方式显著下降。对照受试者和DM - NR中PNE的变化百分比与p - cAMP的变化呈正相关(分别为r = 0.660和0.449),但在DM - HR中无相关性。三组在服用可乐定后p - GH的变化(δp - GH)和GH积分(曲线下面积)无显著差异。PR的下降与δp - GH(对照受试者:r = 0.082,DM - NR:r = - 0.400,DM - HR:r = 0.242)或GH积分(对照受试者:r = 0.191,DM - NR:r = 0.382,DM - HR:r = 0.162)均无相关性。对照受试者中钠分数排泄(FENa)下降(p < 0.01),DM - NR中升高(p < 0.05),DM - HR中无变化。FENa的变化与PRA和PAC的变化无相关性。(摘要截断于400字)